Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00719
|
|||||
| Drug Name |
Nicotinamide mononucleotide
|
|||||
| Synonyms |
Beta-NMN; Beta-Nicotinamide mononucleotide; Beta-Nicotinamide ribonucleotide; Nicotinamide D-ribonucleotide; Nicotinamide mononucleotide; Nicotinamide nucleotide; Nicotinamide ribonucleotide; Nicotinamide ribotide
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Dietary shortage [ICD11: 5B7Z] | Preclinical | [1] | |||
| Therapeutic Class |
Bone Density Conservation Agents
|
|||||
| Structure |
|
![]() |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C11H15N2O8P
|
|||||
| Canonical SMILES |
C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)(O)[O-])O)O)C(=O)N
|
|||||
| InChI |
InChI=1S/C11H15N2O8P/c12-10(16)6-2-1-3-13(4-6)11-9(15)8(14)7(21-11)5-20-22(17,18)19/h1-4,7-9,11,14-15H,5H2,(H3-,12,16,17,18,19)/t7-,8-,9-,11-/m1/s1
|
|||||
| InChIKey |
DAYLJWODMCOQEW-TURQNECASA-N
|
|||||
| CAS Number |
CAS 1094-61-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 334.22 | Topological Polar Surface Area | 166 | ||
| Heavy Atom Count | 22 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 8 | |||
| XLogP |
-3.5
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:16171
|
|||||
| DT(s) Transporting This Drug | CCC9 | Transporter Info | Cation-chloride cotransporter 9 | Substrate | [2] | |
| References | ||||||
| 1 | Wikipedia: Nicotinamide_mononucleotide | |||||
| 2 | Slc12a8 is a nicotinamide mononucleotide transporter. Nature Metabolismvolume 1, pages4757 (2019). | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
